Amyloid β peptides in plasma in early diagnosis of Alzheimer's disease: A multicenter study with multiplexing
✍ Scribed by P. Lewczuk; J. Kornhuber; E. Vanmechelen; O. Peters; I. Heuser; W. Maier; F. Jessen; K. Bürger; H. Hampel; L. Frölich; F. Henn; P. Falkai; E. Rüther; H. Jahn; Ch. Luckhaus; R. Perneczky; K. Schmidtke; J. Schröder; H. Kessler; J. Pantel; H.-J. Gertz; H. Vanderstichele; G. de Meyer; F. Shapiro; S. Wolf; M. Bibl; J. Wiltfang
- Book ID
- 118441230
- Publisher
- Elsevier Science
- Year
- 2010
- Tongue
- English
- Weight
- 342 KB
- Volume
- 223
- Category
- Article
- ISSN
- 0014-4886
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Thioflavine T (ThT) associates rapidly with aggregated fibrils of the synthetic __β__/A4‐derived peptides __β__(1–28) and __β__(1–40), giving rise to a new excitation (ex) (absorption) maximum at 450 nm and enhanced emission (em) at 482 nm, as opposed to the 385 nm (ex) and 445 nm (em)
## Abstract ## Objectives To investigate the relation of plasma levels of A__β__ peptides (A__β__1‐40 and A__β__1‐42) and apolipoprotein E (APOE) genotype to dementia status, and the duration of Alzheimer's disease (AD) in adults with Down syndrome (DS). ## Methods Adults with DS were recruited